Skip to content

Translating data into
scientific discovery

Count Me In data is catalyzing research and fueling discoveries that are positively
impacting the cancer communities.

See data releases

publications-ft-img-1

img-dots-yellow-purple
Making progress for 
patients everywhere

Patient participation in Count Me In projects has enabled the generation of de-identified clinical datasets that serve as the basis for clinical studies being conducted by researchers and biopharma partners around the world. These studies have led to numerous scientific publications that are translating into real world impacts for patients in need of answers, improved care, and novel treatment for cancers.

Count Me In provides services and access to the tools needed to advance clinical research. Together with patients and our research partners, we are making progress for patients everywhere, but there are many discoveries yet to be made. Join us.

row-7

Data releases

Solving the challenges of living with complex diseases involves assembling the right pieces of a complex puzzle, bringing patients, advocates, researchers, and industry partners together, and empowering them with advanced tools to conduct clinical research studies.

sponsors

Publications

The data provided to Count Me In is being used by researchers around the world in clinical research studies. Published findings from these studies are helping to advance our understanding of cancers and provide a foundation by which we can develop targeted treatments and improve the lives of patients everywhere.

Total

5

Total Publications

2023

 

The Metastatic Breast Cancer Project: leveraging patient-partnered research to expand the clinical and genomic landscape of metastatic breast cancer and accelerate discoveries

Number of citations: 2

2022

 

A patient-driven clinicogenomic partnership for metastatic prostate cancer

Number of citations: 5

 

A Framework for Promoting Diversity, Equity, and Inclusion in Genetics and Genomics Research

Number of citations: 16

2020

 

Prevalence and mutational determinants of high tumor mutation burden in breast cancer

Number of citations: 280

 

The Angiosarcoma Project: enabling genomic and clinical discoveries in a rare cancer through patient-partnered research

Number of citations: 182